Daniel H Robinson is an accomplished inventor based in Lake Bluff, IL (US). He has made significant contributions to the field of pharmaceutical formulations, holding a total of 2 patents. His work focuses on creating stable formulations that enhance the efficacy of therapeutic agents.

Latest Patents

Robinson's latest patents include innovative cosolvent formulations. These stable pharmaceutical formulations consist of a therapeutic agent, a low molecular weight alcohol, and a glycol derivative. One of the preferred formulations disclosed in his patents includes 19-nor-1α,3β,25-trihydroxy-9,10-secoergosta-5,7(E),22(E)-triene. This formulation aims to improve the stability and effectiveness of pharmaceutical products.

Career Highlights

Daniel H Robinson is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on developing advanced pharmaceutical solutions that address various medical needs.

Collaborations

Robinson has collaborated with notable colleagues, including Lukchiu Li and Edward Anthony Pec. These partnerships have contributed to the successful development of his innovative formulations.

Conclusion

Daniel H Robinson's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective formulations. His patents reflect a dedication to advancing medical science and enhancing patient outcomes.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]